Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27491836)

Published in J Am Heart Assoc on August 04, 2016

Authors

Navdeep K Bhatti1, Keyvan Karimi Galougahi1, Yehuda Paz1, Tamim Nazif2, Jeffrey W Moses2, Martin B Leon2, Gregg W Stone2, Ajay J Kirtane2, Dimitri Karmpaliotis2, Sabahat Bokhari1, Mark A Hardy3, Geoffrey Dube4, Sumit Mohan4, Lloyd E Ratner3, David J Cohen4, Ziad A Ali5

Author Affiliations

1: Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY.
2: Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY Cardiovascular Research Foundation, New York, NY.
3: Department of Surgery, New York Presbyterian Hospital and Columbia University, New York, NY.
4: Division of Nephrology, New York Presbyterian Hospital and Columbia University, New York, NY.
5: Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY Cardiovascular Research Foundation, New York, NY zaa2112@columbia.edu.

Associated clinical trials:

ISCHEMIA-Chronic Kidney Disease Trial (ISCHEMIA-CKD) | NCT01985360

Articles cited by this

(truncated to the top 100)

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88

In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47

Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med (1999) 8.14

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 7.41

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med (2016) 6.95

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis (2005) 6.31

Atherosclerosis is an inflammatory disease. Am Heart J (1999) 5.12

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med (2013) 4.32

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care (2004) 4.17

Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med (2000) 4.13

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med (2015) 3.81

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2014) 2.58

Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol (2005) 2.47

Peripheral arterial disease: morbidity and mortality implications. Circulation (2006) 2.37

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol (1996) 2.25

Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol (2008) 2.21

The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant (2007) 2.13

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int (1995) 2.06

Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93

Pulmonary hypertension in patients with end-stage renal disease. Chest (2003) 1.89

Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart (2010) 1.80

Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis (2000) 1.79

Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol (2009) 1.78

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74

Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant (2008) 1.73

Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J (2010) 1.71

Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J Am Coll Cardiol (2011) 1.68

Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial (2002) 1.67

Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol (2011) 1.64

Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant (2004) 1.61

The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol (2009) 1.58

Coronary artery disease in a large renal transplant population: implications for management. Am J Transplant (2011) 1.53

Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int (2009) 1.51

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant (2002) 1.50

Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol (2012) 1.42

Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging (2010) 1.39

Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol (1998) 1.37

Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol (1994) 1.35

Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30

Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol (2006) 1.29

Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol (2005) 1.27

Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie (1999) 1.23

Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int (2001) 1.23

Survival after coronary revascularization among patients with kidney disease. Circulation (2004) 1.19

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2011) 1.16

A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis (1995) 1.14

A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis (2001) 1.13

Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. Am J Pathol (2007) 1.10

Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial (2006) 1.09

Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2012) 1.09

Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol (2003) 1.08

Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2011) 1.08

In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. Mayo Clin Proc (2010) 1.08

Cardiac surgery in patients with dialysis-dependent renal disease. Ann Thorac Cardiovasc Surg (1999) 1.05

Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation (2002) 1.03

A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med (2010) 1.03

Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc (2009) 1.03

Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med (1992) 1.02

Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol (1988) 0.99

Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation (2004) 0.99

Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention (2012) 0.99

A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97

Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol (2000) 0.95

Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clin J Am Soc Nephrol (2010) 0.95

Perioperative risk and management in patients with pulmonary hypertension. Chest (2013) 0.95

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int Suppl (2011) 0.94

Calcific aortic stenosis: a complication of chronic uraemia. Nephron (1987) 0.93

Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective. Clin J Am Soc Nephrol (2006) 0.92

Cardiac surgery in patients on chronic hemodialysis: short and long-term survival. Thorac Cardiovasc Surg (2008) 0.92

Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol (2001) 0.91

Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol (1997) 0.91

Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol (2007) 0.90

Evaluation and management of patients with aortic stenosis. Circulation (2002) 0.89

The effect of successful kidney transplantation on ventricular dysfunction and pulmonary hypertension. Transplant Proc (2010) 0.88

Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation (2012) 0.88

Pulmonary hypertension among patients on dialysis and kidney transplant recipients. Ren Fail (2013) 0.87

[Long-term effects of arteriovenous fistula on cardiac structure and function in non-diabetic hemodialysis patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2013) 0.87

Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis. J Cardiovasc Electrophysiol (2015) 0.87

Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol (2006) 0.86

Predicting clinically unrecognized coronary artery disease: use of two- dimensional echocardiography. Cardiovasc Ultrasound (2009) 0.86

Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease. J Am Coll Cardiol (2011) 0.86

Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study. Circulation (2013) 0.86

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial. Circ Cardiovasc Interv (2015) 0.85

Pulmonary Hypertension and Right Heart Failure in Chronic Kidney Disease: New Challenge for 21st-Century Cardionephrologists. Cardiorenal Med (2013) 0.85

A call to action: variability in guidelines for cardiac evaluation before renal transplantation. Clin J Am Soc Nephrol (2011) 0.85

Echocardiography-based score to predict outcome after renal transplantation. Heart (2006) 0.85

Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes. Clin Nephrol (2003) 0.85

Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. Am J Kidney Dis (2015) 0.84

Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J (2016) 0.84

Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). Am J Cardiol (2011) 0.83

Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes. Am J Transplant (2002) 0.83

Improvement of mitral dysfunction after kidney transplantation. Transplant Proc (2002) 0.83

Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. J Thorac Cardiovasc Surg (2011) 0.83

Congestive heart failure in patients with chronic kidney disease and on dialysis. Am J Med Sci (2003) 0.83

Determinants of early and late results of combined valve operations and coronary artery bypass grafting. Ann Thorac Surg (1996) 0.82